Aline Agneessens SRL
Aline Agneessens reported total assets of 333,441 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Aline Agneessens shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +83 % Total assets +74 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Aline Agneessens's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 43,542 € | ||||
| Equity | 322,253 € | ||||
| Cash | 75,414 € | ||||
| EBITDA | 75,389 € | ||||
| Total assets | 333,441 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 20 Aug 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Aline Agneessens's financial analysis
- Solvency96.6%sector median: 69.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Aline Agneessens
Aline Agneessens's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0644.573.512
- VAT number
- BE0644573512
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 16 Dec 2015
- Registered office
- 1200 Woluwe-Saint-Lambert
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- General medical practice activities (NACE 86210)
Aline Agneessens (SRL) has been based in Woluwe-Saint-Lambert since 2015, active in: general medical practice activities. For 2025, it reports a net profit of 43,542 € and equity of 322,253 €; its revenue is not published. Its solvency stands at 96.6%, above the median of its sector (69.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Aline Agneessens
Companies in the same business, of comparable size and area, outside its group.
- Gailly Assurances Charleroi · balance sheet 333,451 €
- BeNy Land Other information service activities Lubbeek · balance sheet 333,464 €
- VOLA Market research and public opinion polling Ghent · balance sheet 333,345 €
- Storr Belgium Rental and operating of own or leased real estate Kraainem · balance sheet 333,101 €
- Vansimaeys Eric Docteur Medical specialists activities Woluwe-Saint-Pierre · balance sheet 333,808 €
- Docteur Heinen Limbourg · balance sheet 333,420 €
- Brigandshoeve Westerlo · balance sheet 333,556 €
- CABINET PEDIATRIQUE Dr VINCENT BERNIER Visé · balance sheet 333,570 €
Frequently asked questions about Aline Agneessens
What is the revenue of Aline Agneessens?
Aline Agneessens files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Aline Agneessens?
In Belgium, the VAT number is the company number prefixed with BE: BE0644573512 for Aline Agneessens, if the company is VAT-registered. Its company number (CBE) is 0644.573.512.
Where is the registered office of Aline Agneessens?
According to the CBE register, the registered office of Aline Agneessens is in 1200 Woluwe-Saint-Lambert.
What is the equity of Aline Agneessens?
At the close of the 2025 financial year, the equity of Aline Agneessens amounts to 322,253 €, a solvency of 96.6% of total assets.
Who manages Aline Agneessens?
The register lists 1 active mandates at Aline Agneessens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Aline Agneessens
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →